Emergent BioSolutions Receives $44M CDC Contract to Further Advance Vaccinia Immune Globulin Intravenous Program
August 13, 2015 at 07:03 AM EDT
Emergent BioSolutions Inc. (NYSE: EBS) today announced that the Centers for Disease Control and Prevention (CDC) has exercised options ...
